AstraZeneca Pharma India Limited (the Company) has signed a Letter of Intent (LOI) with Strand Life Sciences Private Limited (Strand) to explore opportunities to collaborate in healthcare in India. Strand is described as a genomics research and diagnostics company and a subsidiary of Reliance Industries Limited.

The Company specifically disclosed that it and Strand are not related parties, and the execution of the LOI does not constitute a related party transaction.

Communication regarding this development was disseminated through the Company's LinkedIn handle, accessible at AstraZeneca India. The information is also available on the Company's website at www.astrazeneca.com/india.

This formal intimation was submitted to both BSE Limited and National Stock Exchange of India Limited for record purposes. The letter was digitally signed by Tanya Sanish, Company Secretary & Compliance Officer (ACS No. A25784), on November 17, 2026, at 13:50:33 +05:30.